The Lerman Renovascular Research Lab at Mayo Clinic studies causes and treatments related to nephropathy from atherosclerotic ...

Kidney injury molecule–1 (KIM-1) has emerged as a potential prognostic biomarker for response to therapy and could be used to ...

Patients suffering from Chronic Kidney Disease (CKD) who are progressing from stage 4 chronic disease to stage 5, End-Stage Renal Disease (ESRD), typically need dialysis when they reach stage 5. When ...

Correlates of immunotherapy response in metastatic clear cell renal cell carcinoma from circulating cell-free epigenomes. Association of baseline KIM-1 and KIM-1 change on treatment with outcomes.